全文获取类型
收费全文 | 15526篇 |
免费 | 1310篇 |
国内免费 | 475篇 |
专业分类
耳鼻咽喉 | 190篇 |
儿科学 | 335篇 |
妇产科学 | 52篇 |
基础医学 | 1130篇 |
口腔科学 | 2383篇 |
临床医学 | 858篇 |
内科学 | 2409篇 |
皮肤病学 | 156篇 |
神经病学 | 319篇 |
特种医学 | 484篇 |
外国民族医学 | 1篇 |
外科学 | 5410篇 |
综合类 | 1738篇 |
现状与发展 | 2篇 |
预防医学 | 264篇 |
眼科学 | 340篇 |
药学 | 672篇 |
6篇 | |
中国医学 | 405篇 |
肿瘤学 | 157篇 |
出版年
2024年 | 31篇 |
2023年 | 325篇 |
2022年 | 721篇 |
2021年 | 894篇 |
2020年 | 593篇 |
2019年 | 636篇 |
2018年 | 644篇 |
2017年 | 608篇 |
2016年 | 554篇 |
2015年 | 548篇 |
2014年 | 997篇 |
2013年 | 1114篇 |
2012年 | 777篇 |
2011年 | 927篇 |
2010年 | 659篇 |
2009年 | 694篇 |
2008年 | 727篇 |
2007年 | 673篇 |
2006年 | 656篇 |
2005年 | 622篇 |
2004年 | 546篇 |
2003年 | 469篇 |
2002年 | 401篇 |
2001年 | 339篇 |
2000年 | 240篇 |
1999年 | 253篇 |
1998年 | 237篇 |
1997年 | 182篇 |
1996年 | 158篇 |
1995年 | 139篇 |
1994年 | 137篇 |
1993年 | 91篇 |
1992年 | 118篇 |
1991年 | 91篇 |
1990年 | 68篇 |
1989年 | 72篇 |
1988年 | 49篇 |
1987年 | 43篇 |
1986年 | 49篇 |
1985年 | 50篇 |
1984年 | 27篇 |
1983年 | 19篇 |
1982年 | 26篇 |
1981年 | 19篇 |
1980年 | 23篇 |
1979年 | 18篇 |
1978年 | 19篇 |
1977年 | 7篇 |
1976年 | 12篇 |
1975年 | 5篇 |
排序方式: 共有10000条查询结果,搜索用时 520 毫秒
11.
12.
《Journal of vascular and interventional radiology : JVIR》2020,31(4):630-634
PurposeTo retrospectively evaluate the safety and effectiveness of the Covera stent graft (SG) for the treatment of dysfunctional or thrombosed arteriovenous grafts (AVGs).Materials and MethodsWithin 29 months (February 2016–August 2018), 79 patients underwent Covera SG placement in the authors’ department for the treatment of dysfunctional AVGs. Data were available for 64 patients who underwent 64 procedures, using 64 devices. Minimum follow-up was 6 months, unless reintervention occurred. Mean follow-up was 277 days (6–923 days). Treatment characteristics were 51 cases with venous-graft anastomosis (VGA) stenosis (79.7%), 13 cases of puncture zone stenosis (20.3%), 14 cases of in SG stenosis (21.9%), 8 cases of pseudoaneurysm treatment (12.5%) (1 treatment area might have had more than 1 characteristic). Thirty-six patients presented with thrombosis (56.2%), and 31 of 64 case were de novo treatment areas (48.4%). Primary outcome measurements were technical success and post-intervention primary patency (PIPP) at 6 months, whereas secondary outcome measurements included factors influencing primary outcome.ResultsTechnical success was 100%. Median PIPP was 336 days, and 73.6% of treatment areas were patent at 6 months. There were no significant differences in terms of PIPP when de novo treatment areas were compared with restenotic areas (519 vs. 320 days, respectively; P = .1); patients who presented with versus those who presented without thrombosis (320 vs. 583 days, respectively; P = .07); puncture zone stenosis or elsewhere (329 vs. 686 days, respectively; P = .52); and VGA stenosis or elsewhere (336 vs. 335 days, respectively; P = .9).ConclusionsUse of the Covera SG for AVG treatment was safe and effective in every type of treatment area presented in this retrospective analysis. 相似文献
13.
Changes in Right Ventricular Shape and Deformation Following Coronary Artery Bypass Surgery—Insights from Echocardiography with Strain Rate and Magnetic Resonance Imaging
下载免费PDF全文
![点击此处可从《Echocardiography (Mount Kisco, N.Y.)》网站下载免费的PDF全文](/ch/ext_images/free.gif)
14.
15.
16.
17.
18.
海水浸泡爆炸伤延期植皮最佳时机的研究 总被引:1,自引:0,他引:1
目的确定海水浸泡爆炸伤延期植皮的最佳时机。方法建立海水浸泡爆炸伤动物模型后,分别于0、3、7、14d切取创面组织作病理切片,镜下观察创面受床的病理改变;同期对创区实施植皮术,通过计算机全自动图像分析系统准确计算出各组的皮片成活率。结果分别于伤后0、3、7、14d,对皮肤缺损区施行植皮术,发现不同时机植皮成活率不同,伤后7d对海水浸泡爆炸伤皮肤缺损区植皮,皮片成活率最高。结论海水浸泡爆炸伤延期7d后植皮是对创面实施植皮术的最佳时机。 相似文献
19.
20.
R. Watson T. Kozlowski V. Nickeleit J. T. Woosley J. L. Schmitz S. L. Zacks J. H. Fair D. A. Gerber K. A. Andreoni 《American journal of transplantation》2006,6(12):3022-3029
Antibody-mediated rejection (AMR) after liver transplantation is recognized in ABO incompatible and xeno-transplantation, but its role after ABO compatible liver transplantation is controversial. We report a case of ABO compatible liver transplantation that demonstrated clinical, serological and histological signs of AMR without evidence of concurrent acute cellular rejection. AMR with persistently high titers of circulating donor specific antibodies resulted in graft injury with initial centrilobular hepatocyte necrosis, fibroedematous portal expansion mimicking biliary tract outflow obstruction, ultimately resulting in extensive bridging fibrosis. Immunofluorescence microscopy demonstrated persistent, diffuse linear C4d deposits along sinusoids and central veins. Despite intense therapeutic intervention including plasmapheresis, IVIG and rituximab, AMR led to graft failure. We present evidence that an antibody-mediated alloresponse to an ABO compatible liver graft can cause significant graft injury independent of acute cellular rejection. AMR shows distinct histologic changes including a characteristic staining profile for C4d. 相似文献